CAR-T cells

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Donor-derived CAR-T Cells in the Treatment of AML Patients

Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application